Przegląd Gastroenterologiczny

Abstract

3/2021 vol. 16
Review paper

Gullo’s syndrome – what do we know?

  1. Department of Gastroenterology with Endoscopy Unit, Medical University, Lublin, Poland
  2. Public, Academic Hospital No. 4, Lublin, Poland
Gastroenterology Rev 2021; 16 (3): 181–183
Online publish date: 2020/11/22
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Benign pancreatic hyperenzymemia (Gullo’s syndrome) is characterized by a more than threefold increase of the serum pancreatic enzymes lipase and amylase activity in the absence of any pancreatic disease. Recently, there is an increase in describing cases of Gullo’s syndrome in medical literature. Gullo’s syndrome is a diagnosis of exclusion, and clinicians should be aware of various other conditions which can cause elevation of pancreatic enzymes. However, the diagnostic pathway should be done with the right accuracy to avoid unnecessary examinations.
Share
without publication fees